首页|期刊导航|肿瘤学与转化医学（英文）|Research progress on lung cancer stem cells in epidermal growth factor receptor-tyrosine kinase inhibitor targeted therapy resistance in lung adenocarcinoma

Research progress on lung cancer stem cells in epidermal growth factor receptor-tyrosine kinase inhibitor targeted therapy resistance in lung adenocarcinoma

Hong Zhang Yanbin Wang Xianglin Yuan Yanmei Zou Hua Xiong

肿瘤学与转化医学（英文）2024，Vol.10Issue(1)：42-46,5.

肿瘤学与转化医学（英文）2024，Vol.10Issue(1)：42-46,5.DOI:10.1097/ot9.0000000000000028

Research progress on lung cancer stem cells in epidermal growth factor receptor-tyrosine kinase inhibitor targeted therapy resistance in lung adenocarcinoma

Hong Zhang ¹Yanbin Wang ¹Xianglin Yuan ¹Yanmei Zou ¹Hua Xiong¹

作者信息

1. Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
折叠

摘要

关键词

Drug resistance/EGFR-TKIs/Lung cancer stem cells/Lung adenocarcinoma

Key words

Drug resistance/EGFR-TKIs/Lung cancer stem cells/Lung adenocarcinoma

引用本文复制引用

Hong Zhang,Yanbin Wang,Xianglin Yuan,Yanmei Zou,Hua Xiong..Research progress on lung cancer stem cells in epidermal growth factor receptor-tyrosine kinase inhibitor targeted therapy resistance in lung adenocarcinoma[J].肿瘤学与转化医学（英文）,2024,10(1):42-46,5.

基金项目

This project was supported by the Natural Science Foundation of Hubei Province(no.2021CFB372 to Hua Xiong). （no.2021CFB372 to Hua Xiong）

肿瘤学与转化医学（英文）

OACSTPCD

ISSN：2095-9621

访问量0

下载量0

段落导航